Back to
Centiva Capital, LP
MRNA
Showing 6 of 22 quarters
Position history for
Centiva Capital, LP's holdings in Moderna, Inc.
No. Centiva Capital exited its MRNA (Moderna) position in Q2 2026. Its Q1 2026 13F listed 2,733 shares worth $138,836. Centiva Capital first reported MRNA in Q2 2020 and held it in 15 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$305,279
Total Shares Change
-4,568
Quarter-by-Quarter History